(L to R) SEED Therapeutics president James Tonra; Eisai, Corporate Officer for External Innovation Takashi Owa; SEED Therapeutics coFounder Ning Zheng; SEED Therapeutics coFounder Avram Hershko; SEED ...
Cell culture-produced adeno-associated viral (AAV) vectors have gained momentum as one of the most effective gene and protein delivery tools and are an integral part of both vaccine production and ...
This story was reported with support from Pennsylvania Gets It Done and the BusinessPA team at the Pennsylvania Department of Community and Economic Development. Their work connecting businesses to ...